2m 2m 2m 2m 2m 2m 2m
Opko Health (OPK)
NASDAQ
$1.44+$0.04 (+2.86%)
Price as of Jun 03, 2026 6:43 PM EDT- $1.1BMarket Cap
- 1.45%1-Year Change
- Diagnostics & ResearchIndustry
Opko Health (OPK)
$1.44+$0.04 (+2.86%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 370.3M -48.08% | 713.1M -17.41% | 863.5M -14.01% | 1.0B -43.42% | |
Cost of Revenue | 307.4M -37.86% | 494.6M -9.43% | 546.1M -23.97% | 718.3M -39.80% | |
Gross Profit | 143.0M -34.55% | 218.5M -31.15% | 317.4M +11.02% | 285.9M -50.84% | |
Sales and Marketing Expense | 223.0M -26.70% | 304.2M +1.22% | 300.6M -19.35% | 372.7M -20.51% | |
Research and Development Expense | -124.0M +17.89% | -105.2M +17.44% | -89.6M +21.26% | -73.9M -3.86% | |
Depreciation and Amortization Expense | 91.6M -6.67% | 98.2M -6.76% | 105.3M -3.09% | 108.7M +38.03% | |
Total Operating Expenses | 724.3M -16.29% | 865.2M -15.22% | 1.0B -17.06% | 1.2B -29.93% | |
Operating Profit | -117.4M -22.79% | -152.1M -3.16% | -157.0M -30.60% | -226.3M -1,306.68% | |
Interest Income | 14.8M +75.78% | 8.4M +111.55% | 4.0M +101.06% | 2.0M +6,975.00% | |
Interest Expense | 0 N/A | 0 +100.00% | -13.5M N/A | 0 N/A | |
Interest Income and Expense and Net | 14.8M +75.78% | 8.4M +188.48% | -9.5M -580.72% | 2.0M +6,975.00% | |
Total Nonoperating Income and Expense | -124.0M -187.48% | 141.7M +619.10% | -27.3M -83.48% | -165.3M +404.23% | |
Income before Taxes | -241.4M +2,229.32% | -10.4M -94.38% | -184.3M -52.92% | -391.5M +2,691.39% | |
Income Taxes | -15.7M -136.67% | 42.8M +865.61% | 4.4M +106.99% | -63.5M -509.96% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Net Income | -225.7M +324.02% | -53.2M -71.82% | -188.9M -42.49% | -328.4M +989.49% | |
Net Income from Continuing Operations Applicable to Common | -225.7M +324.02% | -53.2M -71.82% | -188.9M -42.49% | -328.4M +989.49% | |
Basic EPS and Net Income | -0.30 +275.00% | -0.08 -68.00% | -0.25 -45.65% | -0.46 +820.00% | |
Diluted EPS and Net Income | -0.30 +275.00% | -0.08 -68.00% | -0.25 -45.65% | -0.46 +820.00% | |
Basic Weighted Average Shares | 751.1M +8.23% | 694.0M -7.68% | 751.8M +4.55% | 719.1M +10.95% | |
Diluted Weighted Average Shares | 751.1M +8.23% | 694.0M -7.68% | 751.8M +4.55% | 719.1M +10.95% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 382.7M -14.11% | 445.6M +364.76% | 95.9M -37.41% | 153.2M +13.72% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 382.7M -14.11% | 445.6M +364.76% | 95.9M -37.41% | 153.2M +13.72% | |
Total Current Assets | 581.9M -12.11% | 662.1M +113.94% | 309.5M -21.56% | 394.5M -52.06% | |
Accumulated Depreciation | 125.6M -9.43% | 138.7M -11.73% | 157.1M +10.34% | 142.4M +6.81% | |
Property and Plant and Equipment and Net | 73.9M +5.41% | 70.1M -7.02% | 75.4M -8.99% | 82.9M +3.95% | |
Total Long-Term Assets | 19.5M +5.05% | 18.5M +104.15% | 9.1M +4.62% | 8.7M -8.97% | |
Total Assets | 1.9B -12.19% | 2.2B +9.37% | 2.0B -7.18% | 2.2B -9.69% | |
Income Taxes Payable | 126.2M -10.34% | 140.8M +11.06% | 126.8M +0.27% | 126.4M -14.86% | |
Total Short-Term Debt | 10.3M -31.75% | 15.0M -44.97% | 27.3M -25.41% | 36.6M +149.01% | |
Total Current Liabilities | 146.7M -24.04% | 193.1M -3.48% | 200.1M -6.29% | 213.5M -35.31% | |
Total Long-Term Debt | 85.0M -51.03% | 173.6M -19.00% | 214.3M +1.88% | 210.4M +11.94% | |
Total Long-Term Liabilities | 517.3M -19.38% | 641.7M +51.90% | 422.4M +7.73% | 392.1M +1.96% | |
Total Liabilities | 664.0M -20.46% | 834.8M +34.10% | 622.5M +2.79% | 605.6M -15.25% | |
Retained Earnings | -2.3B +10.93% | -2.1B +2.65% | -2.0B +10.36% | -1.8B +20.57% | |
Total Stockholders Equity | 1.3B -7.14% | 1.4B -1.71% | 1.4B -11.04% | 1.6B -7.33% | |
Total Shares Outstanding | 789.9M +12.63% | 701.4M -10.31% | 781.9M +0.08% | 781.3M +13.22% | |
Cash Flow | |||||
Cash from Operating Activities | -178.5M -2.70% | -183.5M +550.74% | -28.2M -70.38% | -95.2M -348.30% | |
Capital Expenditures | 12.3M -50.91% | 25.0M +53.67% | 16.3M -33.78% | 24.6M -23.57% | |
Cash from Investing Activities | 230.3M -34.61% | 352.2M +2,035.45% | -18.2M -119.99% | 91.0M +153.24% | |
Dividends Paid | N/A N/A | N/A N/A | 0 -100.00% | 33.0M N/A | |
Cash from Financing Activities | -118.1M -164.10% | 184.2M +1,729.36% | -11.3M -149.21% | 23.0M +321.92% | |
Financials Ratio | |||||
Gross Margin | 16.99% -44.54% | 30.64% -16.64% | 36.76% +29.12% | 28.47% -13.12% | |
Operating Margin | -31.71% +48.70% | -21.32% +17.26% | -18.18% -19.29% | -22.53% -2,232.59% | |
Return on Assets | -10.92% +332.20% | -2.53% -72.04% | -9.04% -37.15% | -14.38% +1,062.44% | |
Return on Equity | -17.14% +343.54% | -3.86% -69.81% | -12.80% -36.72% | -20.23% +1,026.37% | |
Revenue Growth | -48.08% +176.12% | -17.41% +24.27% | -14.01% -67.73% | -43.42% -283.67% | |
Current Ratio | 3.97 +15.70% | 3.43 +121.64% | 1.55 -16.29% | 1.85 -25.90% | |
Cash Ratio | 2.61 +13.07% | 2.31 +381.47% | 0.48 -33.21% | 0.72 +75.80% | |
Debt-to-Equity Ratio | 0.08 -45.62% | 0.14 -20.59% | 0.17 +9.99% | 0.16 +31.53% | |
Debt-to-Assets Ratio | 0.05 -42.47% | 0.09 -28.64% | 0.12 +5.35% | 0.11 +35.07% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow